Skip to main content
SpringerLink
Log in

Influence of sequential exposure to R-verapamil or B8509-035 on rhodamine 123 accumulation in human lymphoblastoid cell lines

  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

Modulators for the reversal of multidrug resistance such as R-verapamil and B8509-035, a dihydropyridine, effectively overcome multidrug resistance in vitro and are currently undergoing clinical trial. One problem with their use is the application protocol; the question as to whether they should be given by continuous administration or in sequential doses in combination with the cytotoxic drugs has to be addressed. Therefore, we examined the influence of the exposure time and the sequence of modulator administration on the active transport of the fluorescent dye rhodamine 123 (R123), a substrate for the P-glycoprotein, in the resistant lymphoblastid cell line VCR1000 and the parental nonresistant cell line CCRFCEM. Our results demonstrate the importance of coadministration of R-verapamil and the cytotoxic agent for the modulation of multidrug resistance, whereas the exposure sequence does not seem to be such an essential parameter in the case of B8509-035. This observation should be considered for the further design of clinical studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bissett D, Kerr DJ, Cassidy J, Meredith P, Traugott U, Kaye SB (1991) Phase I and pharmacokinetic study ofD-verapamil and doxorubicin. Br J Cancer 64: 1168

    Google Scholar 

  2. Cass CE, Janowska-Wieczorek A, Lynch M, Sheinin H, Hindenburg AA, Beck WT (1989) Effect of duration of exposure to verapamil on vincristine activity against multidrug-resistant human leukemic cell lines. Cancer Res 49: 5798

    Google Scholar 

  3. Cairo MS, Siegel SS, Sender L (1989) Clinical trial of continuous infusion verapamil, bolus vinblastine, and continuous infusion VP16 in drug resistant pediatric tumors. Cancer Res 49: 1063

    Google Scholar 

  4. Cordon-Cardo C, O'Brien JP, Boccia J, Casalis D, Bertino JR, Melamed MR (1990) Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 38: 1277

    Google Scholar 

  5. Dalton WS, Grogan TM, Meltzer PS, Scheper RJ, Durie BGM, Taylor CW, Miller TP, Salmon SE (1989) Drug resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. J Clin Oncol 8: 415

    Google Scholar 

  6. Demicheli R, Jirillo A, Bonciarelli G, Lonardi F, Balli M, Bandello A (1989) 4′-Epidoxorubicin plus verapamil in anthracycline-refractory cancer patients. Tumori75: 245

    Google Scholar 

  7. Ferry DR, Russell MA, Cullen MH (1992) P-glycoprotein possesses a 1,4-dihydropyridine-selective drug acceptor site which is alloserically coupled to a vinca-alkaloid-selective binding site. Biochem Biophys Res Commun 188: 440

    Google Scholar 

  8. Friche E, Skovsgaard T, Nissen NI (1987) Effect of verapamil on daunorubicin accumulation in Ehrlich ascites tumor cells. Cancer Chemother Pharmacol 19: 35

    Google Scholar 

  9. Gekeler V, Frese G, Diddens H, Probst H (1988) Expression of a P-glycoprotein gene is inducible in a multidrug-resistant human leukemia cell line. Biochem Biophys Res Commun 155: 754

    Google Scholar 

  10. Gietzen K, Abdallah F, Bai G (1990) Selective inhibition of proliferation by a novel dihydropyridine derivative with anti-calmodulin activity in the mamma tumor cell line ZR-75-1.Med Sci Res 18: 627

    Google Scholar 

  11. Goldstein LJ, Galski H, Fojo A, et al (1989) Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81: 116

    Google Scholar 

  12. Gottesman MM, Pastan I (1988) The multidrug transporter, a double-edged sword. J Biol Chem 263: 12163

    Google Scholar 

  13. Gruber A, Peterson C, Reizenstein P (1988)D-Verapamil andL-verapamil are equally effective in increasing vincristine accumulation in leukemic cells in vitro. Int J Cancer 41: 224

    Google Scholar 

  14. Häußermann K, Benz B, Gekeler V, Schumacher K, Eichelbaum M (1991) Effects of verapamil enantiomers and major metabolites on the cytotoxicity of vincristine and daunomycin in human lymphoma cell lines. Eur J Clin Pharmacol 40: 53

    Google Scholar 

  15. Hamada H, Tsuruo T (1986) Functional role for the 170-to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc Natl Acad Sci USA 83:7785

    Google Scholar 

  16. Hofmann J, Ueberall F, Egle A, Grunicke H (1991) B-859-35, a new drug with anti-tumor activity, reverses multi-drug resistance. Int J Cancer 47: 870

    Google Scholar 

  17. Hofmann J, Wolf A, Spitaler M, Böck G, Drach J, Ludescher C, Grunicke H (1992) Reversal of multidrug resistance by B859-35, a metabolite of B859-35, niguldipine, verapamil and nitrendipine. J Cancer Res Clin Oncol 118: 361

    Google Scholar 

  18. Kartner N, Ling V (1989) Multidrug resistance in cancer. Sci Am 260: 44

    Google Scholar 

  19. Kamiwatari M, Gagata U, Kikuche H, Yoshimura A, Sumizawa T, Shudo N, Sakoda R, Seto K, Akiyama S (1989) Correlation between reversing of multidrug resistance and inhibiting of3H-azidopine photolabeling of P-glycoprotein by newly synthesized dihydropyridine analogues in a human cell line. Cancer Res 49: 3190

    Google Scholar 

  20. Kessel D (1986) Interactions among membrane transport systems: anthracyclines, colcium antagonists and anti-estrogens. Biochem Pharmacol 35: 2825

    Google Scholar 

  21. Kessel D, Beck WT, Kukuruga D, Schulz V (1991) Characterization of multidrug resistance by fluorescent dyes. Cancer Res 51: 4665

    Google Scholar 

  22. Kuwazuru Y, Yoshimura A, Hanada S, Utsunomiya A, Makino T, Ishibashi K, Kodama M, Iwahashi M, Arima T, Akiyama S (1990) Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance. Cancer 66: 868

    Google Scholar 

  23. Lampidis TJ, Castello C, Del Gilio A, Pressman BC, Viallet P, Trevorrow KW, Valet GK, Tapiero H, Savaraj N (1989) Relevance of the chemical charges of rhodamine dyes to multiple drug resistance. Biochem Pharmacol 38: 4267

    Google Scholar 

  24. Ludescher C, Gattringer C, Drach J, Hofmann J, Grunicke H (1991) Rapid functional assay for the detection of multidrug-resistant cells using the fluorescent dye rhodamine 123. Blood 78: 1385

    Google Scholar 

  25. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55

    Google Scholar 

  26. Roller E, Benz B, Eichelbaum M, Gekeler V, Häußermann K, Klumpp B, Schumacher K (1992) Reversal of multidrug resistance with a new calcium/calmodulin antagonist. In: Hiddemann W, Büchner T, Plunkett B, Keating M, Wörmann B, Andreeff M (eds) Acute leukemias-pharmacokinetics. Springer, Berlin Heidelberg New York, p 40

    Google Scholar 

  27. Safa AR, Glover CJ, Meyers MB, Biedler JL, Felsted RL (1987) Identification of the multidrug resistance-related membrane glycoprotein as an acceptor for calcium channel blockers. J Biol Chem 262: 7884

    Google Scholar 

  28. Sasaki DT, Dumas SE, Engleman EG (1987) Discrimination of viable and non-viable cells using propidium iodide in two-color immunofluorescence. Cytometry 8: 413

    Google Scholar 

  29. Tsuruo T, Iida H, Nojiri M, Tsukagoshi S, Sakurai Y (1983) Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers. Cancer Res 43: 2905

    Google Scholar 

  30. Volm M, Bak M, Efferth T, Mattern J (1989) Induced multidrug resistance in murine leukemia L1210 and associated changes in a surface-membrane glycoprotein. J Cancer Res Clin Oncol 115: 17

    Google Scholar 

  31. Yusa K, Tsuruo T (1989) Reversal of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells. Cancer Res 49:5002

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Oncology and Immunology, Robert-Bosch-Hospital, Auerbachstrasse 110, W-7000, Stuttgart 50, Germany

    Elke Roller, Britta Klumpp, Jessica Krause & Kurt Schumacher

  2. Dr. Margarete Fischer-Bosch-Institute for Clinical Pharmacology, Robert-Bosch-Hospital, W-7000, Stuttgart 50, Germany

    Michel Eichelbaum

Authors
  1. Elke Roller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Britta Klumpp
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jessica Krause
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michel Eichelbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Kurt Schumacher
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

This research was supported by the Robert-Bosch-Foundation, Stuttgart, Germany

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roller, E., Klumpp, B., Krause, J. et al. Influence of sequential exposure to R-verapamil or B8509-035 on rhodamine 123 accumulation in human lymphoblastoid cell lines. Cancer Chemother. Pharmacol. 32, 151–155 (1993). https://doi.org/10.1007/BF00685619

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00685619

Keywords

Search

Navigation